TELCON RF PHARMACEUTICAL.

KOSDAQ-200230
KOSDAQ
Technology Communication Equipment
Global Rank
#30699
Country Rank
#1803
Market Cap
46.22 M
Price
3.63
Change (%)
5.62%
Volume
119,173

TELCON RF PHARMACEUTICAL. (KOSDAQ-200230) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
08/22/2025 3:1 x3 x15 Forward
12/10/2024 1:10 x0.1 x5 Reverse
09/07/2016 5:1 x5 x50 Forward
08/12/2016 5:1 x5 x10 Forward
07/11/2016 2:1 x2 x2 Forward

Frequently Asked Questions

  • How much would TELCON RF PHARMACEUTICAL. stock be worth if it never split?
    If TELCON RF PHARMACEUTICAL. (stock symbol: KOSDAQ-200230) had never undergone any stock splits, its price per share today would be approximately 54.41 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 3-for-1) that occurred on 08/22/2025.
  • TELCON RF PHARMACEUTICAL. (stock symbol: KOSDAQ-200230) has undergone a total of five stock splits. The most recent split occurred on 08/22/2025. One share bought prior to the first split on 07/11/2016 would now equal 15.00 shares.
  • TELCON RF PHARMACEUTICAL. (stock symbol: KOSDAQ-200230) has undergone five stock splits in its history. The most recent split, a 2-for-1 split, occurred on 08/22/2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.